Skip to main content
NCBI home page
Japanese Journal of Cancer Research : Gann logoLink to Japanese Journal of Cancer Research : Gann
. 1992 Nov;83(11):1184–1191. doi: 10.1111/j.1349-7006.1992.tb02743.x

Frequent Occurrence of p53 Gene Mutations in Uterine Cancers at Advanced Clinical Stage and with Aggressive Histological Phenotypes

Hitoshi Tsuda 1, Setsuo Hirohashi 1
PMCID: PMC5918705  PMID: 1336492

Abstract

The clinical and pathological significance of mutation of the p53 tumor‐suppressor gene was examined in 108 cases of primary uterine cancers using single‐strand conformation polymorphism and direct DNA sequencing analyses. Mutation of the p53 gene was detected in 19 (31%) of 62 cases of cancer of the uterine corpus and was more frequent in groups at an advanced clinical stage and/or with aggressive histology. Among four adenocarcinomas arising in the lowest portion of the uterine corpus, three showed integration of human papillomavirus (HPV) types 16 and/or 18 DNA, and two of them also showed p53 mutation. In cancer of the uterine cervix, p53 mutations were rare; 1% (3/46) in total, 3% (1/30) of cases with integration of HPV types 16 and/or 18 DNA and 13% (2/16) of cases without HPV DNA integration. Three mutations were detected among two cases at clinical stage IV and two cases of undifferentiated cervical carcinoma. Immunohistochemically, all five cases of uterine cancer which showed diffuse (>50% of cancer cells) nuclear staining of p53 protein also carried the p53 mutation. Therefore, p53 alterations were suggested to be involved in the development of uterine cancers showing aggressive biological behavior. Although a high incidence of HPV DNA integration and a low incidence of pS3 mutation were confirmed in cancer of the uterine cervix, there was no inverse association between integration of HPV types 16 and/or 18 DNA and p53 mutation.

Keywords: Cancer of uterine corpus, Cancer of uterine cervix Immunohistochemistry, Human papillomavirus

Full Text

The Full Text of this article is available as a PDF (751.0 KB).

REFERENCES

  • 1. ) Nigro , J. M. , Baker , S. J. , Preisinger , A. C. , Jessup , J. M. , Hostetter , R. , Cleary , K. , Binger , S. H. , Davidson , N. , Baylin , S. , Devilee , P. , Glover , T. , Collins , F. S. , Weston , A. , Modali , R. , Harris , C. C. and Vogelstein , B.Mutations in the p53 gene occur in diverse human tumour types . Nature , 342 , 705 – 708 ( 1989. ). [DOI] [PubMed] [Google Scholar]
  • 2. ) Baker , S. J. , Preisinger , A. C. , Jessup , J. M. , Paraskeva , C. , Markowitz , S. , Willson , J. K. V. , Hamilton , S. and Vogelstein , B.p53 gene mutations occur in combination with 17 p allelic deletions as late events in colorectal tumorigenesis . Cancer Res. , 50 , 7717 – 7722 ( 1990. ). [PubMed] [Google Scholar]
  • 3. ) Oren , M. , Maltzman , W. and Levine , A. J.Post‐translational regulation of the 54K cellular tumour antigen in normal and transformed cells . Mol Cell Biol. , 1 , 101 – 110 ( 1981. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. ) Finlay , C. A. , Hinds , P. W. , Tan , T.‐H. , Eliyahu , D.Oren , M. and Levine , A. J.Activating mutations for transformation by p53 produce a gene product that forms an hsc70‐p53 complex with an altered half‐life . Mol. Cell Biol , 8 , 531 – 539 ( 1988. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. ) Rodrigues , N. R. , Rowan , A. , Smith , M. E. F. , Kerr , I. B. , Bodmer , W. F. , Gannon , J. V. and Lane , D. P.p53 mutations in colorectal cancer . Proc. Natl. Acad. Sci. USA , 87 , 7555 – 7559 ( 1990. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. ) Bartek , J. , Bartkova , J. , Vojtesek , B. , Staskova , Z. , Rejthar , A. , Kovarik , J. and Lane , D. P.Patterns of expression of the p53 tumour suppressor in human breast tissues and tumours in situ and in vitro . Int. J. Cancer , 46 , 839 – 844 ( 1990. ). [DOI] [PubMed] [Google Scholar]
  • 7. ) Iggo , R. , Gatter , K. , Bartek , J. , Lane , D. and Harris , A. L.Increased expression of mutant forms of p53 oncogene in primary lung cancer . Lancet , 335 , 675 – 679 ( 1990. ). [DOI] [PubMed] [Google Scholar]
  • 8. ) Iwaya , K. , Tsuda , H. , Hiraide , H. , Tamaki , K. , Tamakuma , S. , Fukutomi , T. , Mukai , K. and Hirohashi , S.Nuclear p53 immunoreaction associated with poor prognosis of breast cancer . Jpn. J. Cancer Res. , 82 , 835 – 840 ( 1991. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. ) Hiyoshi , H. , Matsuno , Y. , Kato , H. , Shimosato , Y. and Hirohashi , S.Clinicopathological significance of nuclear accumulation of tumor suppressor gene p53 product in primary lung cancer . Jpn. J. Cancer Res. , 83 , 101 – 106 ( 1992. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. ) Okamoto , A. , Sameshima , Y. , Yamada , Y. , Teshima , S. , Terashima , Y. , Terada , M. and Yokota , J.Allelic loss on chromosome 17p and p53 mutations in human endometrial carcinoma of the uterus . Cancer Res. , 51 , 5632 – 5636 ( 1991. ). [PubMed] [Google Scholar]
  • 11. ) Kohler , M. F. , Berchuck , A. , Davidoff , A. M. , Humphrey , P. A. , Dodge , R. K. , Iglehart , J. D. , Soper , J. T. , Clarke‐Pearson , D. L. , Bast , R. C. and Marks , J. R.Overexpression and mutation of p53 in endometrial carcinoma . Cancer Res. , 52 , 1622 – 1627 ( 1992. ). [PubMed] [Google Scholar]
  • 12. ) Poulsen , H. E. and Taylor , C. W. “ International Histological Classification of Tumours No. 13. Histological Typing of Female Genital Tract Tumours ,” pp. 15 – 24 ( 1975. ). World Health Organization; , Geneva . [Google Scholar]
  • 13. ) Abeler , V. M. and Kørstad , K. E.Serous papillary carcinoma of the endometrium: a histopathological study of 22 cases . Gynecol. Oncol , 39 , 266 – 271 ( 1990. ). [DOI] [PubMed] [Google Scholar]
  • 14. ) Sambrook , J. , Fritsch , E. F. and Maniatis , T. “ Molecular Cloning. A Laboratory Manual ,” 2nd Ed. pp. 9.14 – 9.23 , E.3‐E.4 ( 1989. ). Cold Spring Harbor Laboratory Press; , Cold Spring Harbor . [Google Scholar]
  • 15. ) Orita , M. , Suzuki , Y. , Sekiya , T. and Hayashi , K.Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction . Genomics , 5 , 874 – 879 ( 1989. ). [DOI] [PubMed] [Google Scholar]
  • 16. ) Suzuki , Y. , Sekiya , T. and Hayashi , K.Allele‐specific polymerase chain reaction: a method for amplification and sequence determination of a single component among a mixture of sequence variants . Anal. Biochem. , 192 , 82 – 84 ( 1991. ). [DOI] [PubMed] [Google Scholar]
  • 17. ) Gyllenstein , U. B. , and Erlich , H. A.Generation of single‐stranded DNA by the polymerase chain reaction and its application to direct sequencing of the HLA‐DQA locus . Proc. Natl, Acad. Sci. USA , 85 , 7652 – 7656 ( 1988. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. ) Dürst , M. , Gissmann , L. , Ikenberg , H. and zur Hausen , H.A human papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions . Proc. Natl. Acad. Sci. USA , 80 , 3812 – 3815 ( 1983. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. ) Boshart , M. , Gissmann , L. , Ikenberg , H. , Kleinheinz , A. , Scheurlen , W. and zur Hausen , H.A new type of papillomavirus DNA, its prevalence in genital cancer biopsies and in cell lines derived from cervical cancer . EMBO J. , 3 , 1151 – 1157 ( 1984. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. ) Sato , Y. , Mukai , K. , Watanabe , S. , Goto , M. and Shimosato , Y.The AMeX method: a simplified technique of tissue processing and paraffin embedding with improved preservation of antigens for immunostaining . Am. J. Pathol. , 125 , 431 – 435 ( 1986. ). [PMC free article] [PubMed] [Google Scholar]
  • 21. ) Banks , L. , Matlashewski , G. and Crawford , L.Isolation of human p53 specific monoclonal antibodies and their use in the studies of human p53 expression . Eur. J. Biochem. , 159 , 529 – 534 ( 1986. ). [DOI] [PubMed] [Google Scholar]
  • 22. ) Levine , A. J. , Momand , J. and Finlay , C. A.The p53 tumour suppressor gene . Nature , 351 , 453 – 456 ( 1991. ). [DOI] [PubMed] [Google Scholar]
  • 23. ) Ng , A. B. P. and Reagan , J. W.Incidence and prognosis of endometrial carcinoma by histologic grade and extent . Obstet. Gynecol. , 35 , 437 – 443 ( 1970. ). [PubMed] [Google Scholar]
  • 24. ) Salazar , O. M. , DePapp , E. W. , Bonfiglio , T. A. , Feldstein , M. L. , Rubin , P. and Rudolph , J. H.Adenosquamous carcinoma of the endometrium. An entity with an inherent poor prognosis ? Cancer , 40 , 119 – 130 ( 1977. ). [DOI] [PubMed] [Google Scholar]
  • 25. ) Kempson , R. L. and Bari , W.Uterine sarcomas. Classification, diagnosis, and prognosis . Hum. Pathol. , 1 , 331 – 349 ( 1970. ). [PubMed] [Google Scholar]
  • 26. ) Silverberg , S. G. and DeGiorgi , L. S.Clear cell carcinoma of the endometrium . Cancer , 31 , 1127 – 1140 ( 1973. ). [DOI] [PubMed] [Google Scholar]
  • 27. ) Jenkins , J. R. , Chumakov , P. , Addison , C. , Stürzbecher , H.‐W. and Wade‐Evans , A.Two distinct regions of the murine p53 primary amino acid sequence are implicated in stable complex formation with simian virus 40 T antigen . J. Virol , 62 , 3903 – 3906 ( 1988. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. ) Hollstein , M. , Sidransky , D. , Vogelstein , B. and Harris , C. C.p53 mutations in human cancers . Science , 253 , 49 – 53 ( 1991. ). [DOI] [PubMed] [Google Scholar]
  • 29. ) Scheffner , M. , Werness , B. A. , Huibregtse , J. M. , Levine , A. J. and Howley , P. M.The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53 . Cell , 63 , 1129 – 1136 ( 1990. ). [DOI] [PubMed] [Google Scholar]
  • 30. ) Crook , T. , Wrede , D. , Tidy , J. A. , Mason , W. P. , Evans , D. J. and Vousden , K. H.Clonal p53 mutation in primary cervical cancer: association with human‐papillomavirus‐negative tumours . Lancet , 339 , 1070 – 1073 ( 1992. ). [DOI] [PubMed] [Google Scholar]
  • 31. ) Reich , N. C. and Levine , A. J.Growth regulation of a cellular tumour antigen, p53, in nontransformed cells . Nature , 308 , 199 – 201 ( 1984. ). [DOI] [PubMed] [Google Scholar]
  • 32. ) Steinmeyer , K. , Maacke , H. and Peppert , W.Cell cycle control by p53 in normal (3T3) and chemically transformed (Meth A) mouse cells. I. Regulation of p53 expression . Oncogene , 5 , 1691 – 1699 ( 1990. ). [PubMed] [Google Scholar]
  • 33. ) Stürzbecher , H. ‐W. , Mainets , T. , Chumakov , P. , Brain , R. , Addison , C. , Simanis , V. , Rudge , K‐ , Philip , R. , Grimaldi , M. , Court , W. and Jenkins , J. R.p53 interacts with p34cdc2 in mammalian cells: implication for cell cycle control and oncogenesis . Oncogene , 5 , 795 – 801 ( 1990. ). [PubMed] [Google Scholar]

Articles from Japanese Journal of Cancer Research : Gann are provided here courtesy of Wiley

RESOURCES